| Name | Plozalizumab |
|---|
| Description | Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research[1]. |
|---|---|
| Related Catalog | |
| Target |
CCR2 |
| References |
| No Any Chemical & Physical Properties |